Summary
Preserved language function is essential to quality of life. For patients with a brain tumor near putative language
cortex, neurosurgeons may use functional magnetic resonance imaging (fMRI) presurgical language mapping to
assess and mitigate the risks of surgery-induced permanent language deficits. Critical barriers to clinical
deployment of presurgical fMRI are that 1) The validity of conventional fMRI is contingent on the patient’s ability
to perform precisely timed phonological and semantic tasks. But up to 50% of patients assigned to fMRI have
language or other cognitive deficits that affect task performance and may invalidate the mapping. 2) Expertise
in administering language tasks is insufficient in many clinical settings. To tackle these challenges, we propose
a single-group clinical trial to test movie fMRI (in which subjects watch short movie clips while being scanned)
as a novel diagnostic intervention for language mapping in neurosurgical patients. Our primary hypothesis is that
movie-watching relative to task-based and resting-state fMRI can provide comprehensive language mapping in
a greater number of neurosurgical patients, especially those with language deficits. Compared to conventional
fMRI language mapping tasks, movie-watching is predicted to engage more completely the neural networks
supporting language in real life. Movie-watching also improves subject compliance in fMRI scanning. Our
preliminary results demonstrate reduced in-scanner head motion, higher mapping sensitivity in receptive
language areas, and overall higher language mapping specificity, of movie versus conventional task fMRI, in
brain tumor patients undergoing presurgical language mapping (n=34). In this project, Aim 1 will evaluate in
individuals with stroke-induced aphasia (n=80) and healthy controls (n=40), the comprehension and expression
elicited by movie-watching versus conventional paradigms, as a function of language impairment. We predict
that language performance will be comparable, and in most individuals with aphasia superior, for movie-watching
relative to the other paradigms. Aim 2 will assess in neurologically-healthy subjects (n=40), the quality of movie
fMRI language mapping as a function of movie clip, and relative to conventional paradigms, using indices of
language localization sensitivity and specificity, hemispheric lateralization, and proximity to language white-
matter tracts. We predict that for clips inducing the most sensitive and specific synchronized fMRI activation,
movie-fMRI will produce better language mapping quality indices than the other paradigms. Aim 3 will similarly
evaluate movie-fMRI in neurosurgical patients with frontal or temporoparietal gliomas (n=80), as a function of
baseline language function, against the gold standard intra-operative electrocortical stimulation language
mapping, and relative to post-operative language outcome. We predict that movie-fMRI will produce better
language mapping in a large proportion of patients, especially those with language deficits. Study materials will
be publicly released, including optimal movie clips for certain language deficits and fMRI analysis routines.
Public Health Relevance Statement
Narrative
The goal of this clinical trial is to improve current functional magnetic resonance imaging (fMRI) language
mapping practices for diagnostic neurosurgical planning, including for patients with pre-existing language deficits.
The movie-watching language mapping test that will be developed uses naturalistic stimuli predicted to engage
more completely the neural networks supporting language in real life. Our goal is to test and publicly share a
novel method of comprehensive language mapping which is applicable in more neurosurgical patients, especially
those with language deficits.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AffectAmericanAphasiaAreaAttentionBehavior assessmentBrain MappingBrain NeoplasmsClinicalClinical TrialsClinical Trials Cooperative GroupClipCognitiveCognitive deficitsComprehensionDecision MakingDiagnosticDiffusion Magnetic Resonance ImagingElectrophysiology (science)EpilepsyEquilibriumEvaluationExcisionFosteringFunctional Magnetic Resonance ImagingFutureGenerationsGliomaGoalsHeadIndividualInterventionLanguageLanguage DisordersLifeMapsMediatingMethodsModelingMorphologic artifactsMotionNeurologicNeurosurgeonOperative Surgical ProceduresPaperPatientsPerformancePostoperative PeriodQuality of lifeRecommendationRestScanningSemanticsSensitivity and SpecificitySeveritiesSocietiesSpecificityStandardizationStimulusTask PerformancesTestingcognitive functionfunctional MRI scanimprovedindexinglanguage impairmentlanguage outcomemoviemultimodalityneural networkneuroimagingneurosurgerynovelnovel diagnosticsphonologypreservationresponserisk mitigationstroke-induced aphasiasupport networksurgical riskweb sitewhite matter
National Institute on Deafness and Other Communication Disorders
CFDA Code
173
DUNS Number
030811269
UEI
QN6MS4VN7BD1
Project Start Date
01-April-2023
Project End Date
29-February-2028
Budget Start Date
01-March-2024
Budget End Date
28-February-2025
Project Funding Information for 2024
Total Funding
$709,263
Direct Costs
$495,212
Indirect Costs
$214,051
Year
Funding IC
FY Total Cost by IC
2024
National Institute on Deafness and Other Communication Disorders
$709,263
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01DC020965-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01DC020965-02
Patents
No Patents information available for 5R01DC020965-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01DC020965-02
Clinical Studies
No Clinical Studies information available for 5R01DC020965-02
News and More
Related News Releases
No news release information available for 5R01DC020965-02
History
No Historical information available for 5R01DC020965-02
Similar Projects
No Similar Projects information available for 5R01DC020965-02